Cyclodextrins in oral formulations – has the time of supergenerics come?
Development of generic formulations with cyclodextrins for oral delivery has been neglected for several decades, since the CD-enabled formulations often
Author: Tamas Sohajda
Cyclolab R&D Director
Fraud companies infiltrating cyclodextrin business
I would like to draw your attention to a very recent desperate approach for taking advantage of one’s naivety and
Amgen Submits Supplemental New Drug Application For KYPROLIS® (carfilzomib)
Amgen announced on the 27th August, 2018 the submission of a supplemental New Drug Application (sNDA) to the U.S. Food
Cyclodextrin to formulate proteins – dream or reality
Several cyclodextrins have been claimed by dozens of papers including huge works of Serno [1] and Hartl [2] to be
Improved method for the preparation of SBECD – In which aspect?
Recently, a new patent application became accessible to the public, WO2018146698 (A1), filed by Biophore India, a DMF holder for the
Cyclodextrins at CPHI Worldwide
The biggest pharma exhibition in the world, CPHI Worldwide will be organized 9-11th October in Madrid. By joining (which is
AAPS Pharmsci 360 – exhibition and conference combined (4-7th November)
For those, interested in building relationships with industrial partners as well as broadening their knowledge in state-of-the-art academic research, AAPS
Different cyclodextrins to treat NPC
If you are following advances in the re-discovery of cyclodextrins as APIs, there is quite a race among the candidates
New process to make Sugammadex. Again…
A new patent application has just been published reporting and claiming a new process how to manufacture super-pure Sugammadex. This
Cyclodextrins as theranostics
The application of cyclodextrins as excipients is wellspread, common knowledge worldwide. Their application as APIs is getting huge publicity, developments